Comparison of short-term effects of presurgical nasoalveolar molding and Hotz’s plate on maxillary arch form in unilateral cleft lip and palate

Fuchigami, Takao; Kimura, Namiko; Tezuka, Masahiro; Kibe, Toshiro; Amir, Muhammad Subhan; Tsujii, Toshiya; Suga, Hokuto; Hashiguchi, Makiko; Maeda‐Iino, Aya; Nakamura, Norifumi

doi:10.1016/j.ajoms.2018.08.008

Cited by 2 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of papers (44/87, 50.6%) were confirmed to use unmodified Grayson-Santiago NAM or a minor variation that would be expected to perform similarly to unmodified Grayson-Santiago NAM according to the specific outcomes considered by this review. 20–50 Such acceptable variations included subtleties of device structure or minor changes to the timing of device modifications. 51–62 Many papers (28/87, 32.2%) did not specify the NAM technique that was employed and did not offer an adequate picture of the device or description of the protocol to be appraised.…”

Section: Results: Study Characteristicsmentioning

confidence: 99%

Systematic Review and Critical Appraisal of the Evidence Base for Nasoalveolar Molding (NAM)

Dunworth

Fimbres

Trotta

et al. 2022

The Cleft Palate Craniofacial Journal

View full text Add to dashboard Cite

Objective To critically appraise the body of scientific literature supporting the risks and efficacy of nasoalveolar molding (NAM), specifically in contrast to alternative methods of presurgical infant orthopedics (PSIO) or to treatment without PSIO. Main Outcome Measures Five outcome domains were considered: nasolabial aesthetics; dentoalveolar relationship; midfacial growth; cost and burden of care; and number of anesthetic events. Design MEDLINE, Embase, and Scopus were queried for articles from the first description of the Grayson-Santiago NAM technique (1993) through December 13, 2021. After the application of inclusionary and exclusionary criteria, selected articles were critically appraised using a systematic framework that included risk of bias assessment using the Cochrane RoB 2.0 and ROBINS-I tools. Results A total of 88 studies were included. Level-I and -II evidence showed on par or better approximation and alveolar alignment achieved by NAM compared to other PSIO. Level-II and -III evidence showed improved nasolabial aesthetics compared to other PSIOs. Level-II and -III evidence supported no harm to maxillofacial skeletal growth through age 12. Sparse level-III evidence supported a reduced number of labial or nasal revisions following NAM. Level-II and -III evidence showed NAM requiring upfront cost and frequent appointments but reducing caregiver psychosocial burden and reducing long-term costs compared to select alternatives. Many studies carried a high risk of bias. Conclusions Current evidence supports the overall efficacy of NAM regarding short/mid-term outcomes, with a low risk of negative effects on midfacial growth or dental development. The high risk of bias discovered in many papers underscores the need for robust study design in future research.

show abstract

Section: Results: Study Characteristicsmentioning

confidence: 99%

Systematic Review and Critical Appraisal of the Evidence Base for Nasoalveolar Molding (NAM)

Dunworth

Fimbres

Trotta

et al. 2022

The Cleft Palate Craniofacial Journal

View full text Add to dashboard Cite

show abstract

Short-term surgical outcomes in patients with unilateral complete cleft lip and palate after presurgical nasoalveolar molding therapy: A three-dimensional anthropometric study

et al. 2022

View full text Add to dashboard Cite

ObjectiveThis brief research report aimed to evaluate the short-term efficacy of presurgical nasoalveolar molding (PNAM) therapy on the nasolabial morphology three dimensionally in patients with non-syndromic complete unilateral cleft lip and palate (UCLP).MethodsThirty-six patients with non-syndromic complete unilateral complete cleft lip and palate were enrolled retrospectively and categorized into 2 groups: 18 patients who had received PNAM treatment (PNAM group) and 18 age-matched patients who have not receive PNAM treatment (no PNAM group) from 2017 to 2021. The average starting age for PNAM therapy was 18.33 days, and the average PNAM treatment duration was 99.08 days. Twelve nasolabial parameters were measured to compare the postsurgical outcomes of two groups.ResultsIn PNAM groups, cleft width, vertical distance between double Crista philtri and columellar deviation were reduced compared to that in no PNAM group. And nostril height was larger than that in no PNAM group. The differences between two groups were statistically significant (p < .05). There were no statistical differences in columellar length, nostril width and bi-alar width between two groups. However, the nostril width on cleft side in PNAM group was decreased by an average of 1.1 mm.ConclusionOur result indicated that PNAM therapy decreased cleft width and vertical distance between Crista philtri. It also increased nasal symmetry by decreasing columellar deviation, increasing nostril height.

show abstract

Comparison of short-term effects of presurgical nasoalveolar molding and Hotz’s plate on maxillary arch form in unilateral cleft lip and palate

Cited by 2 publications

References 17 publications

Systematic Review and Critical Appraisal of the Evidence Base for Nasoalveolar Molding (NAM)

Systematic Review and Critical Appraisal of the Evidence Base for Nasoalveolar Molding (NAM)

Short-term surgical outcomes in patients with unilateral complete cleft lip and palate after presurgical nasoalveolar molding therapy: A three-dimensional anthropometric study

Contact Info

Product

Resources

About